Back
 OJAnes  Vol.2 No.4 , September 2012
A Case Study in the Use of Capsaicin in the Treatment of Neuropathic Chest Wall Pain and Post-thoracotomy Intercostal Neuralgia
Abstract: Off label use of Quetenza? (capsaicin 8%) patch in relieving post-thoracotomy neuropathic pain proved temporarily effective, but to a degree indicating limited usefulness in a clinical setting.A 57 year-old male with chronic post-thoracotomy pain was treated with 8% capsaicin topically. Pre-procedure pain was rated as 8 on a 10 point scale, the 30 minute post procedure pain was reported as 2 - 3 on a 10 point scale. Neuralgia was completely resolved for the initial 48 hours post-procedure, then returned gradually over the next 5 days. Because pain transmission pathways are the same in post herpetic and post traumatic neuralgias, the use of 8% capsaicin merits additional study.
Cite this paper: C. Roberts, L. Morgan, K. Hall, P. Kumar and S. Smith, "A Case Study in the Use of Capsaicin in the Treatment of Neuropathic Chest Wall Pain and Post-thoracotomy Intercostal Neuralgia," Open Journal of Anesthesiology, Vol. 2 No. 4, 2012, pp. 99-101. doi: 10.4236/ojanes.2012.24023.
References

[1]   Prescribing Information, Package Insert, “Qutenza? (Capsaicin) 8% Patch”, Initial US Approval: 2009

[2]   M. M. Backonja, “High-Concentration Capsaicin for the Treatment of Post-Herpetic Neuralgia and Other Types of Peripheral Neuropathic Pain,” European Journal of Pain Supplements, Vol. 4, No. 2, 2010, pp. 170-174. doi:10.1016/S1754-3207(10)70529-0

[3]   M. M. Backonja, G. A. Irving, L. R. Webster and J. K. Tobias, “Tolerability of Qutenza (NGX-4010), an 8% Capsaicin Patch, for Postherpetic Neuralgia, (A299),” 2010. http:/asaabstracts.com

[4]   C. M. Campbell, R. R. Edwards, C. Carmona, M. Uhart, G. Wand, A. Carteret, Y. K. Kim, J. Frost and J. N. Campbell, “Polymorphisms in the GTP Cyclohydrolase Gene (GCH1) Are Associated With Ratings of Capsaicin Pain,” Pain, Vol. 141, No. 1-2, 2009, pp. 114-118. doi:10.1016/j.pain.2008.10.023

[5]   P. Anand, “Peripheral and Central Mechanisms of Visceral Sensitization in Man,” Neurogastroenterology Motility, Vol. 19, No. 1, 2007, pp. 29-46. doi:10.1111/j.1365-2982.2006.00873.x

[6]   R. Gerwin, “Myofascial and Visceral Pain Syndromes: Visceral-Somatic Pain Representations,” Clinical Neurobiology of Fibromyalgia and Myofascial Pain, Hayworth Press Inc, 2002, pp. 165-175.

[7]   C. H. M. Rains, “Topical Capsaicin. A Review of Its Pharmacological Properties and Therapeutic Potential In Post-herpetic Neuralgia, Diabetic Neuropathy and Osteoarthritis,” Drugs Aging, Vol. 7, No. 4, 1995, pp. 317328.

 
 
Top